By Susanna Moon
Chicago, March 11 - HSBC USA Inc. priced $7 million of 0% return enhanced notes due March 13, 2017 linked to a basket of three equally weighted stocks, according to a 424B2 filing with the Securities and Exchange Commission.
The underlying companies are AstraZeneca plc, Bristol-Myers Squibb Co. and Merck & Co., Inc.
The payout at maturity will be par plus 195% of any basket gain.
Investors will be exposed to any losses.
J.P. Morgan Securities LLC is the placement agent.
| Issuer: | HSBC USA Inc.
|
| Issue: | Return enhanced notes
|
| Underlying basket: | AstraZeneca plc, Bristol-Myers Squibb Co. and Merck & Co., Inc., equally weighted
|
| Amount: | $7 million
|
| Maturity: | March 13, 2017
|
| Coupon: | 0%
|
| Price: | Par
|
| Payout at maturity: | Par plus 195% of any basket gain; exposure to any losses
|
| Pricing date: | March 6
|
| Settlement date: | March 11
|
| Agent: | J.P. Morgan Securities LLC
|
| Fees: | 0.5%
|
| Cusip: | 40432XW72
|
© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere.
For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.
